350 research outputs found
Hyaluronan and cardiac regeneration
Hyaluronan (HA) is abundantly expressed in several human tissues and a variety of roles for HA has been highlighted. Particularly relevant for tissue repair, HA is actively produced during tissue injury, as widely evidenced in wound healing investigations. In the heart HA is involved in physiological functions, such as cardiac development during embryogenesis, and in pathological conditions including atherosclerosis and myocardial infarction. Moreover, owing to its relevant biological properties, HA has been widely used as a biomaterial for heart regeneration after a myocardial infarction. Indeed, HA and its derivatives are biodegradable and biocompatible, promote faster healing of injured tissues, and support cells in relevant processes including survival, proliferation, and differentiation. Injectable HA-based therapies for cardiovascular disease are gaining growing attention because of the benefits obtained in preclinical models of myocardial infarction. HA-based hydrogels, especially as a vehicle for stem cells, have been demonstrated to improve the process of cardiac repair by stimulating angiogenesis, reducing inflammation, and supporting local and grafted cells in their reparative functions. Solid-state HA-based scaffolds have been also investigated to produce constructs hosting mesenchymal stem cells or endothelial progenitor cells to be transplanted onto the infarcted surface of the heart. Finally, applying an ex-vivo mechanical stretching, stem cells grown in HA-based 3D scaffolds can further increase extracellular matrix production and proneness to differentiate into muscle phenotypes, thus suggesting a potential strategy to create a suitable engineered myocardial tissue for cardiac regeneration
Development of pharmacologically active microcarriers transporting stem cells and releasing growth factors for cardiac stem cell regeneration
Combining adult stem cells and polymeric devices for tissue engineering in infarcted myocardium
An increasing number of studies in cardiac cell therapy have provided encouraging results for cardiac repair. Adult stem cells may overcome ethical and availability concerns, with the additional advantages, in some cases, to allow autologous grafts to be performed. However, the major problems of cell survival, cell fate determination and engraftment after transplantation, still remain. Tissue-engineering strategies combining scaffolds and cells have been developed and have to be adapted for each type of application to enhance stem cell function. Scaffold properties required for cardiac cell therapy are here discussed. New tissue engineering advances that may be implemented in combination with adult stem cells for myocardial infarction therapy are also presented. Biomaterials not only provide a 3D support for the cells but may also mimic the structural architecture of the heart. Using hydrogels or particulate systems, the biophysical and biochemical microenvironments of transplanted cells can also be controlled. Advances in biomaterial engineering have permitted the development of sophisticated drug-releasing materials with a biomimetic 3D support that allow a better control of the microenvironment of transplanted cells
Millimeter wave spectroscopic measurements of stratospheric and mesospheric constituents over the Italian Alps: stratospheric ozone
Measurements of rotational lines emitted by middle atmospheric trace gases have been carried out from the Alpine
station of Testa Grigia (45.9°N, 7.7°E, elev. 3500 m) by means of a Ground-Based Millimeter-wave Spectrometer
(GBMS). Observations of species such as O3, HNO3, CO, N2O, HCN, and HDO took place during 4 winter periods,
from February 2004 to March 2007, for a total of 116 days of measurements grouped in about 18 field campaigns.
By studying the pressure-broadened shape of emission lines the vertical distribution of the observed constituents
is retrieved within an altitude range of ∼17-75 km, constrained by the 600 MHz pass band and the 65 kHz
spectral resolution of the back-end spectrometer. This work discusses the behavior of stratospheric O3 during the
entire period of operation at Testa Grigia. Mid-latitude O3 columnar content as estimated using GBMS measurements
can vary by large amounts over a period of very few days, with the largest variations observed in December
2005, February 2006, and March 2006, confirming that the northern winter of 2005-2006 was characterized by a
particularly intense planetary wave activity. The largest rapid variation from maximum to minimum O3 column values
over Testa Grigia took place in December 2006 and reached a relative value of 72% with respect to the average
column content for that period. During most GBMS observation times much of the variability is concentrated
in the column below 20 km, with tropospheric weather systems and advection of tropical tropospheric air into the
lower stratosphere over Testa Grigia having a large impact on the observed variations in column contents. Nonetheless,
a wide variability is also found in middle stratospheric GBMS O3 measurements, as expected for mid-latitude
ozone. We find that O3 mixing ratios at ∼32 km are very well correlated with the solar illumination experienced by
air masses over the previous ∼15 days, showing that already at 32 km altitude ozone photochemistry dominates over
transport processes. The correlation of lower stratospheric ozone concentrations with potential vorticity as an indicator
of transport is instead not as clear-cut, due to very complex mixing processes that characterize stratospheric
air at mid-latitudes. Correlations of O3 over Testa Grigia with stratospheric tracers such as N2O and HCN, also observed
by means of the GBMS, are planned for the future, in order to better characterize lower stratospheric dynamics
and therefore lower stratospheric ozone concentrations at mid-latitudes
A comparison of acute phase proteins and traditional risk factors as markers of combined plaque and intima-media thickness and plaque density in carotid and femoral arteries
AbstractObjectives: to test the hypothesis that some acute phase proteins may be better independent predictors of objective measures of arterial wall impairment than traditional risk factors. Design: cross-sectional study. Materials and Methods: C-reactive protein (CRP), fibrinogen, C3 complement and traditional risk factors were measured in 288 men aged 55-64 years, randomly chosen from the local registry lists. By ultrasound assessment of the bifurcations of carotid and femoral arteries, maximum combined plaque/intima-media thickness (CPIMTmax) and mean plaque density (MPD, in a grey scale from 0 to 255) were also measured. Results: in multivariate analysis only traditional risk factors remained associated with the overall CPIMTmax: smoking (r = 0.35, p < 0.0001), cholesterol (r = 0.23, p = 0.0001), age (r = 0.22, p = 0.0002), glucose (r = 0.18, p = 0.002) and systolic blood pressure (r = 0.13, p = 0.02). However, with regard to carotid disease only, fibrinogen was the strongest covariate of CPIMT (r = 0.18, p = 0.002). The overall MPD was independently associated with CRP (r = 0.25, p = 0.0008), physical activity (r = 0.19, p = 0.009), triglycerides (r = −0.18, p = 0.02) and body mass index (r = 0.15, p = 0.04). CRP was mainly associated with femoral MPD, while triglycerides were the major (inverse) covariate of carotid MPD. Conclusions: traditional risk factors are the main determinants of CPIMTmax, although fibrinogen seems to play a role in carotids. CRP was associated with high density femoral plaques. Finally, no acute phase protein was independently associated with low density, potentially vulnerable, plaques.Eur J Vasc Endovasc Surg 26, 81-87 (2003
Evolution of temperature, O3, CO, and N2O profiles during the exceptional 2009 Arctic major stratospheric warming as observed by lidar and mm-wave spectroscopy at Thule (76.5°N, 68.8°W), Greenland.
The 2009 Arctic sudden stratospheric warming (SSW) was the most intense event of this kind ever observed. Unique ground-based measurements of middle atmospheric profiles for temperature, O3, CO, and N2O obtained at Thule (76.5°N, 68.8°W), Greenland, in the period January – early March are used to show the evolution of the 2009 SSW in the region of its maximum intensity. The first sign of the SSW was detected at θ~2000 K on January 19, when a rapid decrease in CO mixing ratio took place. The first evidence of a temperature increase was observed at the same level on 22 January, the earliest date on which lidar measurements reached above ~50 km. The warming propagated from the upper to the lower stratosphere in 7 days and the record maximum temperature of 289 K was observed between 1300 and 1500 K potential temperature on 22 January. A strong vortex splitting was associated with the SSW. Stratospheric backward trajectories indicate that airmasses arriving to Thule during the warming peak underwent a rapid compression and an intense adiabatic warming of up to 50 K. The rapid advection of air from the extra-tropics was also occasionally observed to produce elevated values of N2O mixing ratio. Starting from mid-February the temperature profile and the N2O mixing ratio returned to the pre-warming values in the mid and upper stratosphere, indicating the reformation of the vortex at these levels. In late winter, vertical descent from starting altitudes of ~60 km is estimated from CO profiles to be 0.25±0.05 km/day
Pharmacologically active microcarriers for endothelial progenitor cell support and survival
The regenerative potential of endothelial progenitor cell (EPC)-based therapies is limited due to poor cell viability and minimal retention following application. Neovascularization can be improved by means of scaffolds supporting EPCs. The aim of the present study was to investigate whether human early EPCs (eEPCs) could be efficiently cultured on pharmacologically active microcarriers (PAMs), made with poly(d,l-lactic-coglycolic acid) and coated with adhesion/extracellular matrix molecules. They may serve as a support for stem cells and may be used as cell carriers providing a controlled delivery of active protein such as the angiogenic factor, vascular endothelial growth factor-A (VEGF-A). eEPC adhesion to fibronectin-coated PAMs (FN-PAMs) was assessed by means of microscopic evaluation and by means of Alamar blue assay. Phospho ERK(1/2) and PARP-1 expression was measured by means of Western blot to assess the survival effects of FN-PAMs releasing VEGF-A (FN-VEGF-PAMs). The Alamar blue assay or a modified Boyden chamber assay was employed to assess proliferative or migratory capacity, respectively. Our data indicate that eEPCs were able to adhere to empty FN-PAMs within a few hours. FN-VEGF-PAMs increased the ability of eEPCs to adhere to them and strongly supported endothelial-like phenotype and cell survival. Moreover, the release of VEGF-A by FN-PAMs stimulated in vitro HUVEC migration and proliferation. These data strongly support the use of PAMs for supporting eEPC growth and survival and for stimulating resident mature human endothelial cells
Retrieval of foreign-broadened water vapor continuum coefficients from emitted spectral radiance in the H2O rotational band from 240 to 590 cm −1
The paper presents a novel methodology to retrieve the foreign-broadened water vapor continuum absorption coefficients in the
spectral range 240 to 590 cm−1 and is the first estimation of the continuum coefficient at wave numbers smaller than 400 cm−1 under atmospheric conditions. The derivation has been accomplished by processing a suitable
set of atmospheric emitted spectral radiance observations obtained during the March 2007 Alps campaign of the ECOWAR project (Earth COoling by WAter vapor Radiation). It is shown that, in the range 450 to 600 cm−1, our findings are in good agreement with the widely used Mlawer, Tobin-Clough, Kneizys-Davies (MT_CKD) continuum. Below 450 cm−1 however the MT_CKD model overestimates the magnitude of the continuum coefficient.Published15816-158331.8. Osservazioni di geofisica ambientaleJCR Journalreserve
- …